Collector
Novo Nordisk CEO Hints Semaglutide Could Be More Than A Weight-Loss Drug: 'A Bit Of A Longevity Game' | Collector
Novo Nordisk CEO Hints Semaglutide Could Be More Than A Weight-Loss Drug: 'A Bit Of A Longevity Game'
Benzinga

Novo Nordisk CEO Hints Semaglutide Could Be More Than A Weight-Loss Drug: 'A Bit Of A Longevity Game'

Novo Nordisk exploring additional uses for obesity drug semaglutide, including potential for longevity and aesthetics. Importance Rank: 1 read more

Go to News Site